US Stock MarketDetailed Quotes

BridgeBio Pharma (BBIO)

Watchlist
  • 67.405
  • -0.275-0.41%
Close Jun 10 16:00 ET
  • 66.100
  • -1.305-1.94%
Post 16:55 ET
13.20BMarket Cap-18.02P/E (TTM)

About BridgeBio Pharma Company

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

Company Profile

SymbolBBIO
Company NameBridgeBio Pharma
Listing DateJun 27, 2019
Issue Price17.00
ISINUS10806X1028
Founded2015
CEODr. Neil Kumar, PhD
MarketNASDAQ
Employees839
Fiscal Year Ends12-31
Address3160 Porter Drive,Suite 250
CityPalo Alto
ProvinceCalifornia
CountryUnited States of America
Zip Code94304
Phone1-650-391-9740
Websitehttp://www.bridgebio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Neil Kumar, PhD
  • Director; Chief Executive Officer of the Company and Eidos Therapeutics, Inc.
  • 14.94M
  • Maricel M. Apuli
  • Chief Accounting Officer
  • --
  • Dr. Thomas Trimarchi, PhD
  • President and Chief Financial Officer
  • 5.83M
  • Dr. Frank P. McCormick, D.Sc.,F.R.S.,PhD
  • Director
  • 1.10M
  • Jennifer E. Cook
  • Independent Director
  • 599.95K
  • Andrea John Ellis
  • Independent Director
  • 599.95K
  • Ronald J. Daniels
  • Independent Director
  • 599.95K
  • James C. Momtazee
  • Independent Director
  • 599.95K
  • Fred Hassan
  • Lead Independent Director
  • 599.95K
  • Douglas A. Dachille
  • Independent Director
  • 599.95K
  • Ali J. Satvat
  • Independent Director
  • 599.95K
  • Dr. Randal W. Scott,PhD
  • Independent Director
  • 599.95K
  • Dr. Hannah A. Valantine, M.D.
  • Independent Director
  • 599.95K
  • Dr. Eric Aguiar, M.D.
  • Independent Director
  • 599.95K
  • Dr. Andrew W. Lo, PhD
  • Independent Director
  • 649.95K
  • Dr. Charles J. Homcy,M.D.
  • Lead Director
  • 1.12M
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.23%
Sample Name
Sample Code
 +1.31%
Sample Name
Sample Code
 -1.03%
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-2.32%
5
ProShares UltraShort Energy
DUG
-2.99%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +2.95%
Sample Name
Sample Code
 +1.98%
Sample Name
Sample Code
 +1.29%
4
Tencent Music
TME
+0.77%
5
Zai Lab
ZLAB
+0.52%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Tensions in the Middle East are escalating: Iran shot down a U.S. Apache helicopter, prompting retaliatory U.S. airstrikes on multiple locat Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -